469 related articles for article (PubMed ID: 34503252)
21. Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
Baldari S; Di Modugno F; Nisticò P; Toietta G
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230627
[TBL] [Abstract][Full Text] [Related]
22. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Belhabib I; Zaghdoudi S; Lac C; Bousquet C; Jean C
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298680
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
26. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E
Front Immunol; 2021; 12():612271. PubMed ID: 33889150
[TBL] [Abstract][Full Text] [Related]
27. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
28. Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration.
Priwitaningrum DL; Blondé JG; Sridhar A; van Baarlen J; Hennink WE; Storm G; Le Gac S; Prakash J
J Control Release; 2016 Dec; 244(Pt B):257-268. PubMed ID: 27616660
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer: Stroma and its current and emerging targeted therapies.
Kota J; Hancock J; Kwon J; Korc M
Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284
[TBL] [Abstract][Full Text] [Related]
30. Targeting Pancreatic Stellate Cells in Cancer.
Schnittert J; Bansal R; Prakash J
Trends Cancer; 2019 Feb; 5(2):128-142. PubMed ID: 30755305
[TBL] [Abstract][Full Text] [Related]
31. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
Zinger A; Koren L; Adir O; Poley M; Alyan M; Yaari Z; Noor N; Krinsky N; Simon A; Gibori H; Krayem M; Mumblat Y; Kasten S; Ofir S; Fridman E; Milman N; Lübtow MM; Liba L; Shklover J; Shainsky-Roitman J; Binenbaum Y; Hershkovitz D; Gil Z; Dvir T; Luxenhofer R; Satchi-Fainaro R; Schroeder A
ACS Nano; 2019 Oct; 13(10):11008-11021. PubMed ID: 31503443
[TBL] [Abstract][Full Text] [Related]
32. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery.
Bhaw-Luximon A; Jhurry D
Cancer Lett; 2015 Dec; 369(2):266-73. PubMed ID: 26415628
[TBL] [Abstract][Full Text] [Related]
33. The extracellular matrix in tumor progression and metastasis.
Eble JA; Niland S
Clin Exp Metastasis; 2019 Jun; 36(3):171-198. PubMed ID: 30972526
[TBL] [Abstract][Full Text] [Related]
34. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
35. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Guo J; Zeng H; Chen Y
Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronidase-Expressing
Ebelt ND; Zuniga E; Passi KB; Sobocinski LJ; Manuel ER
Mol Cancer Ther; 2020 Feb; 19(2):706-716. PubMed ID: 31694889
[TBL] [Abstract][Full Text] [Related]
37. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
38. The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.
Bolm L; Cigolla S; Wittel UA; Hopt UT; Keck T; Rades D; Bronsert P; Wellner UF
Transl Oncol; 2017 Aug; 10(4):578-588. PubMed ID: 28658650
[TBL] [Abstract][Full Text] [Related]
39. Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Jiang B; Zhou L; Lu J; Wang Y; Liu C; You L; Guo J
Front Oncol; 2020; 10():576399. PubMed ID: 33178608
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
